These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 9423264)
41. Twenty-year follow-up of minimal breast cancer from the Breast Cancer Detection Demonstration Project. Lopez MJ; Smart CR Surg Oncol Clin N Am; 1997 Apr; 6(2):393-401. PubMed ID: 9115504 [TBL] [Abstract][Full Text] [Related]
42. Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern. Berglund P; Stighall M; Jirström K; Rydén L; Fernö M; Nordenskjöld B; Landberg G J Clin Pathol; 2008 Feb; 61(2):184-91. PubMed ID: 17483245 [TBL] [Abstract][Full Text] [Related]
43. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Miller AB; Baines CJ; To T; Wall C CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087 [TBL] [Abstract][Full Text] [Related]
44. Extending the stochastic two-stage model of carcinogenesis to include self-regulation of the nonmalignant cell population. Cox LA Risk Anal; 1992 Mar; 12(1):129-38. PubMed ID: 1574612 [TBL] [Abstract][Full Text] [Related]
45. A continuation ratio random effects model for repeated ordinal responses. Dos Santos DM; Berridge DM Stat Med; 2000 Dec; 19(24):3377-88. PubMed ID: 11122502 [TBL] [Abstract][Full Text] [Related]
46. Failure inference from a marker process based on a bivariate Wiener model. Whitmore GA; Crowder MJ; Lawless JF Lifetime Data Anal; 1998; 4(3):229-51. PubMed ID: 9787604 [TBL] [Abstract][Full Text] [Related]
47. Keeping the noise down: common random numbers for disease simulation modeling. Stout NK; Goldie SJ Health Care Manag Sci; 2008 Dec; 11(4):399-406. PubMed ID: 18998599 [TBL] [Abstract][Full Text] [Related]
48. Identifiability of the joint distribution of age and tumor size at detection in the presence of screening. Hanin L; Yakovlev A Math Biosci; 2007 Aug; 208(2):644-57. PubMed ID: 17303192 [TBL] [Abstract][Full Text] [Related]
49. A distribution of tumor size at detection and its limiting form. Yakovlev AY; Hanin LG; Rachev ST; Tsodikov AD Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6671-5. PubMed ID: 8692876 [TBL] [Abstract][Full Text] [Related]
50. The University of Rochester model of breast cancer detection and survival. Hanin LG; Miller A; Zorin AV; Yakovlev AY J Natl Cancer Inst Monogr; 2006; (36):66-78. PubMed ID: 17032896 [TBL] [Abstract][Full Text] [Related]
51. A stochastic model for the sizes of detectable metastases. Hanin L; Rose J; Zaider M J Theor Biol; 2006 Dec; 243(3):407-17. PubMed ID: 16930629 [TBL] [Abstract][Full Text] [Related]
52. A cure rate survival model under a hybrid latent activation scheme. Borges P; Rodrigues J; Louzada F; Balakrishnan N Stat Methods Med Res; 2016 Apr; 25(2):838-56. PubMed ID: 23264557 [TBL] [Abstract][Full Text] [Related]
53. A distribution of tumor size at detection: an application to breast cancer data. Tsodikov AD; Asselain B; Yakovlev AY Biometrics; 1997 Dec; 53(4):1495-502. PubMed ID: 9423264 [TBL] [Abstract][Full Text] [Related]